MedPath

Correlation between albuminuria and diabetic neuropathy

Not Applicable
Conditions
Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications
Registration Number
CTRI/2022/12/048381
Lead Sponsor
Bhagat Phool Singh Government Medical College for Women
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of T2DM with a disease duration of >=10 year and on multivitamins

Diabetic neuropathy will be defined as:

Patients with diabetes, having or not having clinical symptoms and sign who will have abnormal nerve conduction velocity, including both confirmed and subclinical DPN.

Microalbuminuria will be defined as:

Urinary excretion of 30 to 300 mg of albumin per g of Creatinine.

Macroalbuminuria will be defined as:

More than 300 mg of albumin per g of Creatinine

Exclusion Criteria

i.Patients of kidney transplantation

ii.Patients with non diabetic nephropathy kidney disease

iii.Cervical vertebral and lumbar intervertebral disc herniation

iv.Acute cerebrovascular events

v.Acute coronary events

vi.Transaminase level more than two fold higher than normal

vii.Serum potassium > 5.5 meq/L

viii.Malignant tumor

ix.Limb trauma

x.Thyroid function abnormalities

xi.Alcohol abuse

xii.Intake of neurotoxic medications

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relationship between albuminuria and diabetic pehripheral neuropathy in patients of type 2 diabetes mellitusTimepoint: baseline
Secondary Outcome Measures
NameTimeMethod
Relationship between degree of albuminuria with severity of diabetic pheripheral neuropathyTimepoint: baseline
© Copyright 2025. All Rights Reserved by MedPath